INS and metabolic dysfunction-associated steatotic liver disease: Moreover, n-3 PUFAs also improved insulin signal pathway via modulating membrane fluidity and decreased proinflammatory responses via reducing the levels of TNF-α and IL-6 in NAFLD (133).